Choriogonadotropin alfa - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen AUST R: 170446Active ingredients:
Choriogonadotropin alfa
Dosage form:
Injection, solution
Sponsor:
Merck Healthcare Pty Ltd
Phone:
1800 257 348
|
From
01 Jul 2024
to
31 Dec 2031
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under section 19A. The approval holder, Merck Healthcare Pty Ltd, can be contacted for details on supply on 1800 633 463.
|